Profile
Hikma Ventures is the strategic venture capital arm of Hikma Pharmaceuticals, established in 2015 and based in the United Kingdom. The firm is led by managing director Lana Ghanem and comprises a diverse leadership team dedicated to investing in healthcare-related innovations. They aim to broaden Hikma's offerings and leverage their global presence to enhance value creation and revenue growth. Hikma Ventures is distinct in its strategic approach, focusing on sectors where Hikma's expertise can accelerate company success.
Hikma Ventures invests in digital health and life sciences companies, primarily targeting disruptive technologies and impactful businesses worldwide. They operate with a broad investment mandate, nurturing companies that align with their strategic goals. Their evergreen fund holds $100 million for strategic investments, allowing them to engage in a variety of opportunities without the pressure of a traditional fund timeline.
The firm has made over 20 investments to date, with notable portfolio companies including those in the digital health space and life sciences. While specific companies are not listed in the available resources, Hikma Ventures is recognized for its strategic alignment with promising and technologically advanced healthcare solutions.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.